ADVERTISEMENT
News
Avita Medical
08/08/2024
Avita enters into an exclusive 5-year development and distribution agreement with Regenity Biosciences for a unique collagen-based dermal matrix. Upon 510(k) clearance expected Q424, Avita will make an initial $2.0MM payment followed by additional payments to support manufacturing.